These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37537568)

  • 1. Risk factors for nosocomial rectal colonisation with carbapenem-resistant Gram-negative bacilli in children with haematological malignancies: a case-control study.
    Fang C; Zhou Z; Zhou M; Li J
    Ann Clin Microbiol Antimicrob; 2023 Aug; 22(1):66. PubMed ID: 37537568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey.
    Karaaslan A; Soysal A; Altinkanat Gelmez G; Kepenekli Kadayifci E; Söyletir G; Bakir M
    J Hosp Infect; 2016 Jan; 92(1):67-72. PubMed ID: 26601601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
    Lima EM; Cid PA; Beck DS; Pinheiro LHZ; Tonhá JPS; Alves MZO; Lourenço ND; Santos RQ; Asensi MD; Marques JA; Bandeira CS; Rodrigues CAS; Gomes Junior SCS; Gomes MZR;
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):132. PubMed ID: 32795380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of and risk factors for intestinal colonisation by multidrug-resistant Gram-negative bacteria in patients with haematological malignancies: A systematic review and meta-analysis.
    Luo H; Chen X; Jiang Z; Yan Q
    Int J Antimicrob Agents; 2024 Jan; 63(1):107043. PubMed ID: 38040318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
    Ting SW; Lee CH; Liu JW
    J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal culture could predict carbapenem-resistant organism bloodstream infection and reduce the mortality in haematological patients: A retrospective cohort study.
    Gao S; Yan R; Zhang S; Li L; Zhang R; Fan J; Qin J; Peng Y; Wan D; Cao W; Bian Z
    J Glob Antimicrob Resist; 2024 Mar; 36():96-104. PubMed ID: 38128727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and molecular epidemiology of intestinal colonization by carbapenem-resistant Gram-negative bacteria in patients with hematological diseases: a multicenter case‒control study.
    Hu H; Wang Y; Sun J; Wang Y; Zhou J; Shi Q; Han X; Jiang Y; Wu D; Huang X; Yu Y
    Microbiol Spectr; 2024 Jul; 12(7):e0429923. PubMed ID: 38847538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for and clinical outcomes of carbapenem non-susceptible gram negative bacilli bacteremia in patients with acute myelogenous leukemia.
    Shin DH; Shin DY; Kang CK; Park S; Park J; Jun KI; Kim TS; Koh Y; Hong JS; Choe PG; Park WB; Kim NJ; Yoon SS; Kim I; Oh MD
    BMC Infect Dis; 2020 Jun; 20(1):404. PubMed ID: 32517658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand.
    Kiddee A; Assawatheptawee K; Na-Udom A; Treebupachatsakul P; Wangteeraprasert A; Walsh TR; Niumsup PR
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition of carbapenem-resistant gram-negative bacilli among intensive care unit (ICU) patients with no previous use of carbapenems: Indirect population impact of antimicrobial use.
    Oliveira JDS; Sampaio NCFM; Leite GS; Pereira MADM; Fortaleza CMCB
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1575-1579. PubMed ID: 35156602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development.
    Liao Q; Feng Z; Lin H; Zhou Y; Lin J; Zhuo H; Chen X
    Front Cell Infect Microbiol; 2023; 13():1109418. PubMed ID: 36794004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Papas V; Pitsiolis T; Tsakris A; Nanas S; Roussos C
    Intensive Care Med; 2013 Jul; 39(7):1253-61. PubMed ID: 23604133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection control management and surveillance of carbapenem-resistant Gram-negative bacteria in hematopoietic stem cell recipients.
    Baier C; Beck M; Panagiota V; Lueck C; Kharazipour D; Hintze SC; Bollin R; Ebadi E; Ziesing S; Eder M; Bange FC; Beutel G
    Antimicrob Resist Infect Control; 2019; 8():160. PubMed ID: 31649817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-derived carbapenem-resistant gram-negative bacterial infections in solid organ transplant recipients: Active surveillance enhances recipient safety.
    Mularoni A; Cona A; Campanella M; Barbera F; Medaglia AA; Cervo A; Cuscino N; Di Mento G; Graziano E; El Jalbout JD; Alduino R; Tuzzolino F; Monaco F; Cascio A; Peghin M; Gruttadauria S; Bertani A; Conaldi PG; Mikulska M; Grossi PA
    Am J Transplant; 2024 Jun; 24(6):1046-1056. PubMed ID: 38342183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia.
    Clerici D; Oltolini C; Greco R; Ripa M; Giglio F; Mastaglio S; Lorentino F; Pavesi F; Farina F; Liberatore C; Castiglion B; Tassan Din C; Bernardi M; Corti C; Peccatori J; Scarpellini P; Ciceri F; Castagna A
    Int J Antimicrob Agents; 2021 Jun; 57(6):106335. PubMed ID: 33838223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of topical antibiotics on eradication and acquisition of third-generation cephalosporin and carbapenem-resistant Gram-negative bacteria in ICU patients; a post hoc analysis from a multicentre cluster-randomized trial.
    Plantinga NL; Wittekamp BHJ; Brun-Buisson C; Bonten MJM;
    Clin Microbiol Infect; 2020 Apr; 26(4):485-491. PubMed ID: 31421272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for colonization with multidrug-resistant Gram-negative bacteria and
    Azzini AM; Be G; Naso L; Lambertenghi L; Salerno ND; Coledan I; Bazaj A; Mirandola M; Miotti J; Mazzaferri F; Accordini S; Lo Cascio G; Tacconelli E
    Front Cell Infect Microbiol; 2023; 13():1155320. PubMed ID: 37377644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
    PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
    Lee JY; Kang CI; Ko JH; Lee WJ; Seok HR; Park GE; Cho SY; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6673-6678. PubMed ID: 27572416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, Outcomes and Resource Utilisation in Patients with Carbapenem Non-susceptible Gram-Negative Bacteria in the UK: A Retrospective, Observational Study (CARBAR UK).
    Goldenberg SD; Dodgson AR; Barlow G; Parcell BJ; Jones L; Albur M; Wilson APR; Enoch DA; Marek A; Micallef C; Manissero D; Longshaw C; Lopes S; Gill K
    Adv Ther; 2022 Aug; 39(8):3602-3615. PubMed ID: 35701725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.